Summary: Transcranial Magnetic Stimulation (TMS) has helped many people with treatment-resistant depression, but until now its cellular mechanisms were unclear. New UCLA research shows that an accelerated form of TMS, called aiTBS (accelerated intermittent theta burst stimulation), can physically repair stress-damaged brain circuits. The study demonstrates rapid rebuilding of synaptic structures and identifies a specific class of neurons—intratelencephalic (IT) neurons—as the principal targets of this restorative effect.
Using a novel preclinical model that closely mimics clinical stimulation, researchers observed lost dendritic spines reappear within 24 hours of aiTBS treatment. The work links structural repair in the prefrontal cortex to quick and durable changes in behavior, offering a structural explanation for why accelerated TMS produces both rapid and lasting antidepressant effects.
Key Facts
- Structural scaffolding and stress: Chronic stress causes pyramidal neurons in the prefrontal cortex to lose dendritic spines—small protrusions that form the physical basis for synaptic communication between neurons.
- Cell-type specificity: Rather than affecting the prefrontal cortex broadly, aiTBS selectively restored dendritic spines and functional activity in intratelencephalic (IT) neurons. Neighboring neuron types showed little change, revealing unexpected cellular precision.
- Accelerated treatment: Standard repetitive TMS (rTMS) protocols often span six weeks. The accelerated aiTBS protocol compresses treatment into five days and, in this study, produced measurable structural and behavioral improvements after a single day of stimulation.
- Essential circuitry: When IT neuron activity was selectively blocked, the antidepressant behavioral effects disappeared, demonstrating that these neurons are essential drivers of the therapeutic response.
- Durability of repair: The structural remodeling in IT neurons and the associated behavioral improvements persisted for at least one week after only one day of aiTBS, suggesting that stimulation restores physical connectivity rather than merely producing a transient activity boost.
Source: UCLA
Background: Transcranial Magnetic Stimulation (TMS) is a non-invasive, FDA-approved therapy that uses brief magnetic pulses delivered through a coil on the scalp to stimulate brain activity. It is commonly used for patients with depression who do not respond to medication. While clinicians have observed robust clinical benefits, the precise cellular and circuit-level mechanisms have been difficult to pinpoint.
A multidisciplinary team in the UCLA Neuromodulation Division developed a first-of-its-kind mouse model that mirrors clinical stimulation parameters and allows researchers to stimulate awake animals while measuring brain activity and structure in real time. Working with scientists at the National Institutes of Health, the team exposed mice to chronic stress to model depression-related changes and then applied the accelerated aiTBS protocol.
They found that chronic stress led to widespread loss of dendritic spines in the prefrontal cortex. Remarkably, one day of aiTBS caused rapid regrowth of those synaptic structures specifically on IT neurons, accompanied by an increase in activity in those same cells during depression-related behaviors. This cell-type selective restoration provides a mechanistic explanation for how neuromodulation can produce both rapid relief and sustained benefit.
“This work connects clinical outcomes with cellular-level insight,” said Dr. Scott Wilke, assistant professor of psychiatry and the Penske Family Chair in Neuromodulation at UCLA Health, and co-leader of the study. “For the first time, we can see which brain cells are changed by rapid stimulation and how restoring their structure supports recovery of depression-related behavior.” The study was co-led by Dr. Laura DeNardo, associate professor of physiology at the David Geffen School of Medicine at UCLA.
The research team reports that the AiTBS-driven restoration is not simply a temporary increase in firing. Instead, the treatment rebuilds the physical synaptic scaffolding, enabling normal circuit function to return and adaptive behavior to recover. When IT neuron activity was inhibited during stimulation, behavioral benefits were lost, confirming the causal role of these neurons in the antidepressant response.
Although mouse models cannot capture every aspect of human depression, this study provides strong preclinical evidence that brain stimulation can rapidly effect cellular and circuit-level repair. These insights could guide more targeted and effective neuromodulation approaches for depression and other disorders rooted in circuit dysfunction—such as PTSD, OCD, chronic pain, and tinnitus—by tailoring stimulation to restore specific cellular pathways.
“Every patient is unique,” Wilke noted. “By testing how different stimulation parameters reshape brain circuits in experimental models, we can move toward personalized neuromodulation strategies that target the precise cells and connections underlying symptoms.”
Key Questions Answered:
A: Currently, TMS is primarily FDA-approved for treatment-resistant depression when medications have not worked. As accelerated protocols like aiTBS become more widely studied and clinical use expands, and as we better understand the cellular precision of these treatments, aiTBS may become a more common early-stage option for some patients.
A: Yes. TMS is already used clinically for several conditions beyond depression. Because disorders such as PTSD and OCD involve dysfunction in specific brain circuits, a technique that can restore dendritic spines and circuit function in targeted neurons could help produce longer-lasting relief across multiple psychiatric and neurological conditions.
A: In this study, structural changes in IT neurons and related behavioral improvements were stable for at least one week after a single day of aiTBS. In clinical practice, some patients experience benefits that last months or years, while others may require maintenance sessions to preserve those synaptic connections under ongoing stress.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full by editorial staff.
- Additional context and clarification were added by the editorial team to aid reader understanding.
About this TMS and depression research news
Author: Will Houston
Source: UCLA
Contact: Will Houston – UCLA ([email protected])
Image: Image credit noted by Neuroscience News
Original Research: Findings reported in the journal Cell